ONC
BeOne MedicinesBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
Current thesis
Composite grade B from latest DB weights. Momentum 50.5 / Value 59.4
Posture
Constructive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta 0.0.
What can break
Mixed signals. Wait for cleaner trend confirmation.
Momentum
51
Value
59
Sentiment
N/A
Setup hits (3d)
0 · Net Neutral
AI TargetsBase - · Bull - · Bear -
Data freshness
Prices
As of 2026-07-20
Fundamentals
As of 2026-07-17 • Vendor: Data Vendor v1
Scores
As of 2026-07-20 • Model: HYBRID_IC_RP
AI Memo
Unavailable: No memo yet
Investment thesisAs of 2026-07-20
Investment thesis
As of 2026-07-20
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $415.45
Why
Momentum51 · Δ7d +48.4
Value59 · Δ7d 0.0
SentimentN/A · Δ7d -
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Value · See fundamentals
Momentum
51
40% active weight
Current posture
7d trendImproving
Δ7d
+48.4
Δ21d
+56.3
Value
59
60% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
-0.3
Sentiment
N/A
Coverage pending
No current score
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade B. Momentum 50.5 / Value 59.4
Fundamentals (TTM)As of 2026-07-17
Fundamentals (TTM)
As of 2026-07-17
Market Cap
$36.32B
Beta
0.52
Shares Out
102.3M
P/E (TTM)
615.3
P/S (TTM)
8.15
P/FCF (TTM)
87.32
Rev YoY
+35.7%
EPS YoY
+17028.7%
Gross Margin
+86.2%
Op Margin
+2.2%
Net Debt
-$2.59B
Current Ratio
3.64
As of 2026-07-20 • Updated nightlySource: Internal modelMethodology